{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:35:03Z","timestamp":1787016903045,"version":"build-2736575974"},"reference-count":25,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>\n                      To determine the frequency and clinical presentation of Lyme disease in patients with uveitis and to assess the value of\n                      <jats:italic>Borrelia burgdorferi<\/jats:italic>\n                      serological testing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Retrospective study on all patients with uveitis who were referred to our tertiary hospital were serologically tested for Lyme in our laboratory between 2003 and 2016. Screening consisted of determining\n                      <jats:italic>B. burgdorferi<\/jats:italic>\n                      serum IgG and IgM by ELISA method. The patient\u2019s serology was considered as positive if the ELISA-positive result in IgM and\/or IgG was confirmed by an immunoblot positive in IgM and\/or IgG. Lyme-associated uveitis was diagnosed based on serological results as well as response to antibiotics and exclusion of other diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 430 patients with uveitis (60% women, mean age 49 years) fulfilling inclusion criteria, 63 (14.7%) had an ELISA-positive serology, confirmed by immunoblot for 34 patients (7.9%). The diagnosis of Lyme-associated uveitis was finally retained in seven patients (1.6%). These patients reported either a previous exposure including tick bite or forest walks (n=5), symptoms suggestive of Lyme disease (n=5) and resistance to local and\/or systemic steroids (n=7). Among the remaining 27 positive patients, 22 had other established aetiologies and 5 other were unclassified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The seroprevalence of\n                      <jats:italic>B. burgdorferi<\/jats:italic>\n                      among our patients with uveitis was 7.9% compared with 6 to 8.5% in the general French population which leads to a low predictive value of serological testing. Its use should be reserved for patients with unexplained uveitis, an exposure history, systemic findings suggestive of Lyme disease and steroids resistance.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bjophthalmol-2017-310251","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T20:40:43Z","timestamp":1498682443000},"page":"369-372","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Diagnosis of Lyme-associated uveitis: value of serological testing in a tertiary centre"],"prefix":"10.1136","volume":"102","author":[{"given":"Alexia","family":"Bernard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Kodjikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amro","family":"Abukhashabh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Roure-Sobas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Boibieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Broussolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Seve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,6,28]]},"reference":[{"key":"2020050713004498000_102.3.369.1","unstructured":"Johnson BJB , Aguero-Rosenfeld ME , Wilske B . In: Sood SK , ed. Lyme borreliosis in Europe and North America: epidemiology and clinical practice. Hoboken, NJ, USA: John Wiley & Sons, Inc, 2011."},{"key":"2020050713004498000_102.3.369.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2011.04.002"},{"key":"2020050713004498000_102.3.369.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60103-7"},{"key":"2020050713004498000_102.3.369.4","unstructured":"Haut Conseil de la Sant\u00e9 Publique, La Borreliose de Lyme, groupe de travail. 2014 http:\/\/social-sante.gouv.fr\/IMG\/pdf\/hcspr20140328_borrelioselyme.pdf (accessed 22 Sep 2016)."},{"key":"2020050713004498000_102.3.369.5","unstructured":"Reseau sentinelle de l\u2019Institut national de veille sanitaire. 2016 http:\/\/invs.santepubliquefrance.fr\/Dossiers-thematiques\/Maladies-infectieuses\/Maladies-a-transmission-vectorielle\/Borreliose-de-lyme\/Donnees-epidemiologiques (accessed 10 May 2016)."},{"key":"2020050713004498000_102.3.369.6","unstructured":"Centers for Disease Control and Prevention of Lyme disease in United States. 2015 National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) Division of Vector-Borne Diseases (DVBD). http:\/\/www.cdc.gov\/lyme\/diagnosistesting\/ (accessed 22 Jun 2016)."},{"key":"2020050713004498000_102.3.369.7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu397"},{"key":"2020050713004498000_102.3.369.8","unstructured":"16eme conf\u00e9rence de consensus en th\u00e9rapeutique anti-infectieuse, Borreliose de lyme: d\u00e9marches diagnostique, th\u00e9rapeutiques, et pr\u00e9ventives. 2006 http:\/\/social-sante.gouv.fr\/IMG\/pdf\/2006-lyme-long_2_.pdf (accessed 22 Jun 2016)."},{"key":"2020050713004498000_102.3.369.9","unstructured":"Weinberg R . Ocular involvement in Lyme disease. Am Acad Ophtalmol 2008 https:\/\/www.aao.org\/current-insight\/ocular-involvement-in-lyme-disease (accessed 22 Jul 2016)."},{"key":"2020050713004498000_102.3.369.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)76262-2"},{"key":"2020050713004498000_102.3.369.11","doi-asserted-by":"crossref","first-page":"A58","DOI":"10.1016\/j.revmed.2016.04.271","article-title":"tude Ulisse\u00a0: uv\u00e9ites, \u00e9valuation clinique et m\u00e9dico\u00e9conomique d\u2019une strat\u00e9gie standardis\u00e9e pour le diagnostic \u00e9tiologique","volume":"37","author":"de Parisot","year":"2016","journal-title":"Rev Med Interne"},{"key":"2020050713004498000_102.3.369.12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ajo.2016.04.002","article-title":"No value for routine serologic screening for Borrelia burgdorferi in patients with uveitis in the Netherlands","volume":"166","author":"Kazi","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"2020050713004498000_102.3.369.13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/09273948.2011.568662","article-title":"Difficulties of interpreting Borrelia serology in patients with uveitis","volume":"19","author":"Mackensen","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"2020050713004498000_102.3.369.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.1.62"},{"key":"2020050713004498000_102.3.369.15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1128\/CDLI.2.1.53-56.1995","article-title":"Prevalence of antibodies against Borrelia species in patients with unclassified uveitis in regions in which lyme disease is endemic and nonendemic","volume":"2","author":"Kimura","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"2020050713004498000_102.3.369.16","doi-asserted-by":"crossref","unstructured":"Johnson B . Lyme disease: an Evidence-based approach. hap 4: laboratory Diagnostic testing for Borrelia burgdorferi infection. J.J. Halperin 2011.","DOI":"10.1079\/9781845938048.0073"},{"key":"2020050713004498000_102.3.369.17","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/156.1.183"},{"key":"2020050713004498000_102.3.369.18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-12-199712150-00011"},{"key":"2020050713004498000_102.3.369.19","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000269672.17807.e0"},{"key":"2020050713004498000_102.3.369.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2007.08.015"},{"key":"2020050713004498000_102.3.369.21","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.3.623"},{"key":"2020050713004498000_102.3.369.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-1549(02)00037-8"},{"key":"2020050713004498000_102.3.369.23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/112067219700700309","article-title":"The significance of serum anti-Borrelia antibodies in the diagnostic work-up of uveitis","volume":"7","author":"Mikkil\u00e4","year":"1997","journal-title":"Eur J Ophthalmol"},{"key":"2020050713004498000_102.3.369.24","first-page":"516","article-title":"[Value of serodiagnosis of lyme disease in the evaluation of uveitis]","volume":"18","author":"Salabert","year":"1995","journal-title":"J Fr Ophtalmol"},{"key":"2020050713004498000_102.3.369.25","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.77.8.480"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-310251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T23:51:47Z","timestamp":1659138707000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-310251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,28]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,2,23]]},"published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1136\/bjophthalmol-2017-310251"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310251","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,28]]}}}